Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 4/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28088551 | 0.92 | ALDH1A1 (0.44) | ALDH1A1CYP3A4LMNACA12CA2 | |
| SCHEMBL842514 | 0.84 | CA12 (0.48) | ALDH1A1CYP3A4LMNACA12CA2 | |
| SCHEMBL30887991 | 0.84 | CA12 (0.48) | ALDH1A1CYP3A4LMNACA12CA2 | |
| SCHEMBL21367600 | 0.83 | PGK1 (0.40) | ALDH1A1LMNACA2CA9CA5A | |
| SCHEMBL28294124 | 0.80 | ALDH1A1 (0.44) | ALDH1A1CYP3A4LMNACA12CA2 | |
| SCHEMBL11584197 | 0.79 | NR1H3 (0.42) | HSD17B10MEN1KMT2ATSHRPGK1 | |
| SCHEMBL7966485 | 0.78 | KCNN4 (0.43) | CYP3A4LMNAKIF11NPC1RAB9A | |
| SCHEMBL28294125 | 0.78 | ALDH1A1 (0.42) | ALDH1A1CYP3A4LMNACA12CA2 | |
| SCHEMBL15319724 | 0.77 | TSHR (0.59) | ALDH1A1CYP3A4LMNACA12CA2 | |
| SCHEMBL9651762 | 0.77 | TSHR (0.59) | ALDH1A1CYP3A4LMNACA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1222237-B1 | MATERIALS FOR INDUCING ALIGNMENT IN LIQUID CRYSTALS AND LIQUID CRYSTAL DISPLAYS | ELSICON INC (US) | 2007-04-11 | — | — | EP | disclosed |
| US-6713135-B2 | BRANCHED POLYIMIDE, POLYAMIC ACIDS | ELSICON, INC. | 2004-03-30 | — | — | US | disclosed |
| EP-1222237-A4 | MATERIALS FOR INDUCING ALIGNMENT IN LIQUID CRYSTALS AND LIQUID CRYSTAL DISPLAYS | ELSICON INC (US) | 2003-01-15 | — | — | EP | disclosed |
| EP-1222237-A1 | MATERIALS FOR INDUCING ALIGNMENT IN LIQUID CRYSTALS AND LIQUID CRYSTAL DISPLAYS | Elsicon, Inc. (US) | 2002-07-17 | — | — | EP | disclosed |
| US-6380432-B2 | AROMATIC DIAMINES USEFUL IN PREPARING POLYIMIDES | ELSICON INC. | 2002-04-30 | — | — | US | disclosed |
| US-20010039361-A1 | Materials for inducing alignment in liquid crystal and liquid crystal displays | GIBBONS WAYNE M (US) | 2001-11-08 | — | — | US | disclosed |
| US-20010018099-A1 | Materials for inducing alignment in liquid crystals and liquid crystal displays | ELSICON, INC. | 2001-08-30 | — | — | US | disclosed |
| US-6242061-B1 | POLYAMIC ACIDS, POLYIMIDES | ELSICON INC. | 2001-06-05 | — | — | US | disclosed |
| WO-2001030938-A1 | MATERIALS FOR INDUCING ALIGNMENT IN LIQUID CRYSTALS AND LIQUID CRYSTAL DISPLAYS | ELSICON, INC. (US) | 2001-05-03 | — | — | WO | disclosed |
| US-6194039-B1 | POLYIMIDES, POLYAMIC ACIDS | ELSICON, INC. | 2001-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039361-A1 | Materials for inducing alignment in liquid crystal and liquid crystal displays | DYNC1LI1, DYNC1LI2, DYNLL1 | ALDH1A1 1492/4885CYP3A4 3978/4885LMNA 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.